Fact CheckerSign in

NCT06986096Recruiting

Lifestyle for the BRAin Health - Nutrition and Exercise Training Intervention

Lifestyle for the BRAin Health - Nutrition and Exercise Training Intervention, LIBRA-NET

Source: ClinicalTrials.gov · Last updated 29 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Due to the increasing incidence of dementia and the lack of causal treatment, non-pharmacological interventions represent an attractive and effective therapeutic strategy of neurodegenerative diseases, such as Alzheimer's disease. The aim of the study is to assess the impact of a supervised 9-month intervention with aerobic-strength training and nutritional counseling compared to cognitive training and stretching on the brain, cognitive and motor functions, metabolism, physical fitnes and plasma markers of neurodegenertion in older adults at increased risk of developing Alzheimer's disease.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
15 Jul 2024
Start date
1 Sept 2024
Primary completion date
Dec 2026
Lead sponsor
Slovak Academy of Sciences
NCT number
NCT06986096

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Sept 2024 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent participation in another clinical study.
  • Therapy with cholinesterase inhibitors unless the patient is on a stable dose.

Other illness

  • Presence of a pacemaker or any metal implants (contraindication for MRI examination), or allergy to local anesthetics (contraindication for muscle biopsy).
  • Stroke or myocardial infarction within the last year.
  • Long-term treatment for psychiatric disorders - a depressive syndrome is not an exclusion criterion if it is compensated by therapy.
  • Other diseases of the musculoskeletal or nervous system that potentially interfere with the ability to exercise or cognition - such as severe arthritis, Parkinson's disease, significant essential tremor, epilepsy, etc.

Lab values

  • Presence of severe cardiovascular, liver, or kidney diseases; advanced or poorly controlled diabetes mellitus (HbA1c \>7%), treated with insulin or incretin analogs; cancer or any other severe disease as assessed by the responsible physician. A history of cancer treated with chemotherapy or radiotherapy if within less than 5 years post-treatment.

Other

  • Lack of cooperation, inflexible schedule, or problematic transportation.
  • Insufficient functional capacity or presence of comorbidities that prevent participation in the training program (assessment by an internist, cardiologist, neurologist, orthopedic specialist, or other relevant specialists).
  • Smoking, alcohol dependence, or addiction to other narcotic substances.

Who the study is looking for

  • Non-smokers
  • Signed informed consent
  • Presence of subjective or mild cognitive impairment (SCI/aMCI)
  • Elevated levels of selected biomarkers confirming the presence of a pathological process characteristic of Alzheimer's disease
  • Absence of any psychological, sociological, or geographical factors that could jeopardize participation in the project.

Age in the registry: 60 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Biomedical Research Center Slovak Academy of Sciences
Coordinator of this site? Confirm its status
BratislavaSlovakiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.